ERJ Open Research

Article	Citations
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?	498
Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study	123
Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?	94
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia	87
D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review	75
Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members	72
Global burden of COVID-19 pandemic on healthcare workers	64
Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry	63
Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry	63
Type 2 inflammation in asthma and other airway diseases	57
Mortality and morbidity in obstructive sleep apnoea–hypopnoea syndrome: results from a 30-year prospective cohort study	56
The role of interleukin-17 in asthma: a protective response?	52
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge	51
Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients	51
COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres	47
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit	47
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD	45
Descriptive analysis of long COVID sequela identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients	43
Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study	43
Underestimation of COVID-19 mortality during the pandemic	42
Identification and treatment of T2-low asthma in the era of biologics	40
Diagnosing COVID-19 pneumonia in a pandemic setting: Lung Ultrasound versus CT (LUVCT) – a multicentre, prospective, observational study	40
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey	39
Predicting and preventing hospital readmission for exacerbations of COPD	38
Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough	37

Evaluation of a multicomponent grading system for obstructive sleep apnoea: the Baveno classification	36
Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial	33
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice	33
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characteris	33
Increased circulating levels of angiotensin-(1–7) in severely ill COVID-19 patients	32
Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival	32
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis	31
The burden of exacerbations in mild asthma: a systematic review	31
ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis	30
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective	30
False-negative RT-PCR in SARS-CoV-2 disease: experience from an Italian COVID-19 unit	29
Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial	29
Current clinical methods of measurement of respiratory rate give imprecise values	28
Radiological–pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways?	28
Prevalence, incidence and characteristics of chronic cough among adults from the Canadian Longitudinal Study on Aging	27
Clinical and research priorities for children and young people with bronchiectasis: an international roadmap	26
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis	25
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy	25
Diaphragmatic motion recorded by M-mode ultrasonography: limits of normality	25
What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance	24
International consensus on lung function testing during the COVID-19 pandemic and beyond	24
Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation	24
Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes	24
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes	23
Current and novel treatment options for obstructive sleep apnoea	23
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)	23
A randomised trial of a web-based physical activity self-management intervention in COPD	23
Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial	22
Characteristics and impact of exercise-induced laryngeal obstruction: an international perspective	22
Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion	21
Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series	21
Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension	21
Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition	21
Phenotypic characterisation of early COPD: a prospective case–control study	21
Pulmonary arterial hypertension-associated changes in gut pathology and microbiota	21
Registries and collaborative studies for primary ciliary dyskinesia in Europe	21
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries	21
Treatment of severe stable COPD: the multidimensional approach of treatable traits	20
Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics	20
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients	20
REINVENT: ERS International survey on REstrictive thoracic diseases IN long term home noninvasive VENTilation	20
Predicting mortality during long-term follow-up in pulmonary arterial hypertension	20
Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough?	20
Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire	19
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus	19
Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation	19
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin	19
The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers	19
Diaphragmatic excursion correlates with exercise capacity and dynamic hyperinflation in COPD patients	19
The role of bronchoscopy in patients with SARS-CoV-2 pneumonia	19

Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes	19
Breastfeeding and risk of childhood asthma: a systematic review and meta-analysis	18
Multidisciplinary care in chronic airway diseases: the Newcastle model	18
Telemedicine and virtual respiratory care in the era of COVID-19	18
The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease	18
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe	18
Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis	18
ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group	18
CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018	18
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan	17
Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019	17
The impact of body mass index, central obesity and physical activity on lung function: results of the EpiHealth study	17
Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases	17
Prospective association between use of electronic cigarettes and use of conventional cigarettes: a systematic review and meta-analysis	17
COVID-PCD: a participatory research study on the impact of COVID-19 in people with primary ciliary dyskinesia	17
The prevalence and burden of interstitial lung diseases in the USA	17
Pulmonary function tests in type 2 diabetes: a meta-analysis	17
Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids	17
Parasexual recombination enablesAspergillus fumigatusto persist in cystic fibrosis	17
Effect of maternal asthma exacerbations on perinatal outcomes: a population-based study	17
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study	17
Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids	16
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth	16
Feasibility and clinical utility of ambulatory cough monitoring in an outpatient clinical setting: a real-world retrospective evaluation	16
Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study	16
Remission of adult-onset asthma is rare: a 15-year follow-up study	16
Environmental contamination related to SARS-CoV-2 in ICU patients	16
Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium	16
Expression of endocannabinoid system components in human airway epithelial cells: impact of sex and chronic respiratory disease status	16
Conservative management of COVID-19 associated hypoxaemia	16
Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis	16
Rapid decline of seasonal influenza during the outbreak of COVID-19	16
Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET	16
Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome	16
Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis	16
Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study	15
Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort	15
Revisiting the association between temperature and COVID-19 transmissibility across 117 countries	15
The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports	15
Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models	15
Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation	15
Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres	15
Are symptoms of obstructive sleep apnoea related to good continuous positive airway pressure compliance?	15
Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis	15
Prospective multicentre study on the safety and utility of transbronchial lung cryobiopsy with endobronchial balloon	15
SAS Care 1: sleep-disordered breathing in acute stroke an transient ischaemic attack – prevalence, evolution and association with functional outcome at 3 months, a prospective observational polysomnog	15
Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study	15
Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study	15
Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?	15
Prevalence, time trends and treatment practices of asthma in India: the Global Asthma Network study	15
Lung cancer mortality in Europe and the USA between 2000 and 2017: an observational analysis	15
Which functional outcome measures can we use as a surrogate for exercise capacity during remote cardiopulmonary rehabilitation assessments? A rapid narrative review	14
Analysis of pathological changes in the epithelium in COVID-19 patient airways	14
The opposite effect of human leukocyte antigen genotypes in sarcoidosis and tuberculosis: a narrative review of the literature	14
Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era	14
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK	14
A randomised trial of Mycobacterium w in critically ill patients with COVID-19: ARMY-1	14
Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review	14
Presence of Propionibacterium acnes in granulomas associates with a chronic disease course in Dutch sarcoidosis patients	14
Detection and diagnosis of large airway collapse: a systematic review	14
Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis	14
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough	14
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment	14
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial	14
Validation of the Swedevox registry of continuous positive airway pressure, long-term mechanical ventilator and long-term oxygen therapy	14
Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis	14
Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit	14
Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma	14
Validation of a composed COVID-19 chest radiography score: the CARE project	14
Central airway and peripheral lung structures in airway disease-dominant COPD	14
Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry	14
Respiratory dysfunction in Parkinson's disease: a narrative review	14
Endothelial dysfunction in COPD: a systematic review and meta-analysis of studies using different functional assessment methods	14
Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients	13
A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension	13
Prevalence of stress urinary incontinence in women presenting for evaluation of chronic cough	13
Computed tomography total airway count predicts progression to COPD in at-risk smokers	13
Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD	13
CiliarMove: new software for evaluating ciliary beat frequency helps find novel mutations by a Portuguese multidisciplinary team on primary ciliary dyskinesia	13
Low socioeconomic status relates to asthma and wheeze, especially in women	13

Management of acute COPD exacerbations in Australia: do we follow the guidelines?	13
Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis	13
Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials	13
Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia	13
Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease	13
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)	13
The airway microbiota and exacerbations of COPD	13
Respiratory syncytial virus-associated hospitalisation in children aged ≤5 years: a scoping review of literature from 2009 to 2021	13
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?	13
National clinical audit for hospitalised exacerbations of COPD	13
International BEAT-PCD Consensus Statement for Infection Prevention and Control for Primary Ciliary Dyskinesia in collaboration with ERN-LUNG PCD Core NETWORK and patient representatives	13
Inhaled therapy reduces COPD mortality	13
Respiratory impedance measured using impulse oscillometry in a healthy urban population	13
Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis	13
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions	13
All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era	13
Oximetry neither to prescribe long-term oxygen therapy nor to screen for severe hypoxaemia	12
Asthma in South African adolescents: a time trend and risk factor analysis over two decades	12
Awake or intubated surgery in diagnosis for interstitial lung diseases? A prospective study	12
The interrelationship of chronic cough and depression: a prospective population-based study	12
Rapid prediction of adverse outcomes for acute normotensive pulmonary embolism: derivation of the Calgary Acute Pulmonary Embolism score	12
Severe outcomes of COVID-19 among patients with COPD and asthma	12
Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance	12
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis	12
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol	12
Longitudinal passive cough monitoring and its implications for detecting changes in clinical status	12
Relationship between dietary patterns and COPD: a systematic review and meta-analysis	12
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics	12
Targeted therapy in eosinophilic chronic obstructive pulmonary disease	12
Thoracic ultrasound for malignant pleural effusion: a systematic review and meta-analysis	12
Individual circadian preference (chronotype) is associated with asthma and allergic symptoms among adolescents	12
Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review	12
Cough-provocation tests with hypertonic aerosols	11
Health service utilisation associated with chronic breathlessness: random population sample	11
Clinical application of oscillometry in respiratory diseases: an impulse oscillometry registry	11
Spirometric phenotypes from early childhood to young adulthood: a Chronic Airway Disease Early Stratification study	11
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges	11
Emergency department visits and hospitalisations for asthma, COPD and respiratory tract infections: what is the role of respiratory viruses, and return to school in September, January and March?	11
COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation	11
Acoustic surveillance of cough for detecting respiratory disease using artificial intelligence	11
Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001–2017	11
Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial	11
Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort	11
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia	11
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease	11
Lung function changes over 8 years and testosterone markers in both sexes: UK Biobank	11
Lung function trajectory and biomarkers in the Tasmanian Longitudinal Health Study	11
Treatable traits qualifying for nonpharmacological interventions in COPD patients upon first referral to a pulmonologist: the COPD sTRAITosphere	11
Pulmonary alveolar microlithiasis: no longer in the stone age	11
Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli	11
Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients	11
Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model	11
Bronchoscopically delivered microwave ablation in an in vivo porcine lung model	11
Use of the ReCIVA device in breath sampling of patients with acute breathlessness: a feasibility study	11
Transbronchial cryobiopsy: an effective tool in the diagnosis of lymphoproliferative disorders of the lung	10
Haemophilus influenzaepersists in biofilm communities in a smoke-exposed ferret model of COPD	10
Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review	10
Research advances and clinical management of bronchiectasis: Chinese perspective	10
Bronchial thermoplasty guided by hyperpolarised gas magnetic resonance imaging in adults with severe asthma: a 1-year pilot randomised trial	10
Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography	10
Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin	10
Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK ce	10
Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial	10
Past asthma exacerbation in children predicting future exacerbation: a systematic review	10
The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis	10
The impact of muscle strength on exercise capacity and symptoms	10
Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact	10
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension	10
Epidemiological features and medical care-seeking process of patients with COVID-19 in Wuhan, China	10
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis	10
Pulmonary rehabilitation in long COVID: more than just natural recovery!?	10
Xenon ventilation MRI in difficult asthma: initial experience in a clinical setting	10
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19	10
Alteration in angiotensin-converting enzyme 2 by PM1 during the development of emphysema in rats	10
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review	10
Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population	10
The impact of a heat and moisture exchange mask on respiratory symptoms and airway response to exercise in asthma	10
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data	10
The use of lung ultrasound in COVID-19	10
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma	10
Vascular remodelling in IPF patients and its detrimental effect on lung physiology: potential role of endothelial to mesenchymal transition (EndMT)	10
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough	10
Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy	10
Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care setting	10
Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19	10
Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection	10
Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial	10
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis	9
Comparison of ciliary beat frequencies at different temperatures in young adults	9
Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study	9
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia	9
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion	9
Aetiology, diagnosis and treatment of moderate-to-severe haemoptysis in a North American academic centre	9
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab	9
Endoscopic lung volume reduction with endobronchial valves in very lowDLCOpatients: results from the German Registry – Lungenemphysemregister e.V.	9